Julian Adams - 27 Jul 2022 Form 4 Insider Report for Gamida Cell Ltd.

Role: Chief Executive Officer, Director
Signature: /s/ Joshua F. Patterson, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 27 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 10 Aug 2022, 16:58:13 UTC
Previous filing: 03 Jan 2022
Next filing: 22 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GMDA	Ordinary Shares	Award	$0	+48,500	+64%	$0.000000	124,650	27 Jul 2022	Direct	F1, F2
transaction	GMDA	Ordinary Shares	Award	$0	+68,800	+55%	$0.000000	193,450	27 Jul 2022	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GMDA	Employee Share Option (Right to Buy)	Award	$0	+291,100		$0.000000	291,100	27 Jul 2022	Ordinary Shares	291,100	$2.93	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock unit ("RSU") award was approved by the Board of Directors of the Issuer on January 28, 2022, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on July 27, 2022.
F2	These shares represent an RSU award, which shall vest in three equal annual installments commencing on July 27, 2023. The vesting of the RSUs is subject to the Reporting Person's continuous service through such vesting date.
F3	These shares represent an RSU award, which shall vest in two equal annual installments commencing on December 31, 2022. The vesting of the RSUs is subject to the Reporting Person's continuous service through such vesting date.
F4	The option grant was approved by the Board of Directors of the Issuer on January 28, 2022, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on July 27, 2022.
F5	One fourth (1/4th) of the shares subject to the option award shall vest on July 27, 2023, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.